菲内伦通过增强SDF-1α/CXCR4介导的干细胞调动来预防损伤,在实验性1型糖尿病脏病患者中发挥作用
Paloma Palma-Guzmán1, Elvira Bragado-García1, Esther Durán-Mateos2
1Instituto Pluridisciplinar and Facultad de Farmacia UCM, Madrid, Spain.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|November 5, 2025
概括
菲内伦通过增强干细胞修复机制来保护糖尿病大鼠的脏. 这涉及激活SDF-1α/CXCR4通路并减少有害的MMP,促进愈合.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 再生医学是一种再生医学.
背景情况:
- 糖尿病病 (DKD) 涉及复杂的损伤途径.
- 矿物质皮质类受体抗剂显示出对DKD治疗的潜力.
- 干细胞动员在DKD中的作用仍在调查中.
研究的目的:
- 在1型糖尿病大鼠中研究芬 (FIN) 的脏保护机制.
- 为了确定干细胞衍生因子1 (SDF-1) /CXCR4轴是否调解FIN的保护作用.
- 探索干细胞招募在FIN诱导的脏修复中的参与.
主要方法:
- 在慕尼黑的Wistar Frömter老鼠中诱导的1型糖尿病使用链毒素和高脂肪/高糖饮食.
- 对糖尿病老鼠进行的费涅伦治疗.
- 损伤通过组织学,RT-qPCR,ELISA和生殖图进行评估.
- 分析了SDF-1α,CXCR4和矩阵金属蛋白酶 (MMP) 的表达.
- 免疫光技术用于检测血造干细胞 (HSC) 标记物CD34.4.
主要成果:
- 糖尿病大鼠表现出显著的淋巴结核硬化,炎症和MMP-2/9活性升高.
- 费内伦治疗减少了损伤,包括管状缩和原积累.
- FIN上调调节了SDF-1α和CXCR4的表达,同时降低了非功能性的SDF-1α (5-67).
- 在接受FIN治疗的脏中观察到CXCR4与CD34+HSC的同定位.
结论:
- 芬瑞诺因增强干细胞动员而减轻大鼠糖尿病损伤.
- SDF-1α/CXCR4轴和减少的MMP活性是FIN脏保护作用的关键媒介.
- 金融促进HSC招募到脏,支持脏保护的新机制.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
909
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
909
01:11Renal Failure: Dose Adjustments
426
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
426
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:30Heart Failure V: Medical Management
208
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
208
01:22Heart Failure Drugs: Diuretics
788
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
788
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
255
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
255